Latest News

Date Title Topic
28 Sep 2014 Metastatic NSCLC: New Findings, New Avenues to Explore Lung and other thoracic tumours
28 Sep 2014 Pathway of the Day: Hedgehog Pathology/Molecular biology
28 Sep 2014 ESMO 2014: Second-Line Targeted Treatments in Patients with Advanced Hepatocellular Carcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Adding Cediranib to Chemotherapy Improves Progression-Free Survival for Metastatic or Recurrent Cervical Cancer, Phase II Trial Shows Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Pertuzumab Adds 16 Months Survival Benefit to Trastuzumab and Chemotherapy Treatment for HER2-Positive Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: IMPRESS Trial Data on Continuing Tyrosine Kinase Inhibitor Therapy After Resistance Development in Lung Cancer Reported Lung and other thoracic tumours - Anticancer agents & Biologic therapy
Photo Reportage
27 Sep 2014 ESMO 2014: How to Guide the Selection of Chemotherapy Regimen for Non-Squamous Non-Small Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: Results of LUX-Lung 8, the Largest Prospective Trial to Compare EGFR TKIs in Patients with Relapsed/Refractory Squamous Cell Carcinoma of the Lung Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Customising Chemotherapy in Lung Cancer: New Phase II Data Reported in Two Late-Breaking Studies Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Docetaxel or Pemetrexed in Addition to Cisplatin Achieve Comparable Outcomes in Non-Squamous Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: Rolapitant Plus Granisetron/Dexamethasone in Prevention of Chemotherapy-Induced Nausea and Vomiting Palliative and supportive care
27 Sep 2014 ESMO 2014 Press Release: Immune Checkpoint Inhibitors Provide Antitumour Activity Across Malignant Diseases Immuno-oncology
27 Sep 2014 ESMO 2014: Afatinib vs Methotrexate in Second-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Head and neck cancers - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: TAS-102 Improves Overall- and Progression-Free Survival in Patients With Metastatic Colorectal Cancer Refractory to Standard Therapies Gastrointestinal cancers - Anticancer agents & Biologic therapy